Evidence map›Paper›PMID 37261130›Full record

ArticleBreast care (Basel, Switzerland)2023

Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast Cancer.

Roman Vion, Patricia Fleury, Valérie Blazejewski, Olivier Rigal, Maxime Fontanilles, Justine Lequesne, Frederic Di Fiore, Florian Clatot

Open access · greenAbstract read
In one paragraph

Article in Breast care (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Roman VionDepartment of Medical Oncology, Centre Henri Becquerel, Rouen, France.
Patricia FleuryDepartment of Medical Oncology, Centre Henri Becquerel, Rouen, France.
Valérie BlazejewskiDepartment of Medical Oncology, Centre Henri Becquerel, Rouen, France.
Olivier RigalDepartment of Medical Oncology, Centre Henri Becquerel, Rouen, France.
Maxime FontanillesDepartment of Medical Oncology, Centre Henri Becquerel, Rouen, France.
Justine LequesneClinical Research Unit, Centre Henri Becquerel, Rouen, France.
Frederic Di FioreDepartment of Medical Oncology, Centre Henri Becquerel, Rouen, France.
Florian ClatotDepartment of Medical Oncology, Centre Henri Becquerel, Rouen, France.
Centre Henri BecquerelCentre Virchow-Villermé · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The presence of a breast nurse is recommended to advise and guide early breast cancer patients before and during chemotherapy/radiation therapy, and at the end of planned treatments. Nevertheless, some patients will need extra guidance. Little is known about the predisposing factors for additional requests. Aim and Objective: Determine time, reasons, and risk factors for breast nurse unplanned solicitations. Design and Methods: This monocentric retrospective study included all early breast cancer patients treated with chemotherapy during 1 year. Unplanned solicitations (in person, by phone, or by e-mail) were recorded in the medical file. They were extracted and stratified in four categories: treatment adverse events, medical condition, psychological support, and counselling. Results: 368 unplanned solicitations were observed for 265 patients, 140 patients (52.8%) asked for at least one unplanned solicitation and 57 (21.5%) asked for at least three. There was no significant difference between the four categories. Most of unplanned solicitations occurred significantly during chemotherapy, essentially after first docetaxel infusion (57% of calls). In univariate and multivariate analyses, anxiolytic treatment was significantly associated with more unplanned solicitations (OR = 2, Conclusion: Breast nurse unplanned solicitations during adjuvant or neoadjuvant chemotherapy in early breast cancers are frequent. Even if patients with anxiolytic treatment have a slightly higher risk of solicitation, no typical profile of a patient who will need extra support exists. Because of its known toxicity, the first cycle of docetaxel is associated with a clear increase in solicitations. Despite physicians' consultations, breast nurses guidance, and leaflets on supportive care and treatments side effects, optimal patient management during early breast cancer remains challenging. Further randomized studies testing more customized tools are required to improve patient support.

Indexed as

Breast nurseCancer careChemotherapyEarly breast cancerPhone solicitationUnplanned solicitations

Identifiers

PMID37261130
PMCPMC10228251
OpenAlexW4317037170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.